Jung-Im Shin
Dr. Jung-Im Shin is an epidemiologist at the Johns Hopkins Bloomberg School of Public Health, known for her research on diabetes, obesity, and the implications of emerging treatments for type 1 diabetes. Recently, she co-authored a study highlighting the significant increase in the use of GLP-1 medications among individuals with type 1 diabetes, despite the lack of clinical trial data specifically addressing their safety and effectiveness for this group.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. Jung-Im Shin is a study author and an epidemiologist at the Johns Hopkins Bloomberg School of Public Health.
8